A Study on the Effects of Left Ventricular Unloading in the Setting of VA ECMO Support
Recruiting now · Not applicable
Conditions studied: Cardiogenic Shock
In brief
REMAP ECMO is a registry based platform in which multiple response adaptive randomized clinical trials (trial domains) will be embedded. These trial domains will, in a perpetual way, study the effects of a range of patient management strategies which aim to improve VA ECMO weaning success. A first trial domain will address the effects of left ventricular (LV) unloading through intra-aortic balloon pumping on weaning succes in VA ECMO supported patients.
Key facts
- Study ID
- NCT05913622
- Run by
- Erasmus Medical Center
- People needed
- 430
- Starts
- 2023-06-08
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2025-12-17
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Radboud UMC — Nijmegen, Netherlands (enrolling)
- ZOL Genk — Genk, Belgium (enrolling)
- UZ Gent — Ghent, Belgium (enrolling)
- Erasmus Medical Center — Rotterdam, South Holland, Netherlands (enrolling)
- OLVG — Amsterdam, Netherlands (enrolling)
- Maastricht UMC — Maastricht, Netherlands (enrolling)
- AZ Sint-Jan Brugge — Bruges, Belgium (enrolling)
- University Medical Center Utrecht — Utrecht, Utrecht, Netherlands
- Haga ziekenhuis — The Hague, South Holland, Netherlands
- Antonius hospital — Nieuwegein, Utrecht, Netherlands
- Amphia hospital — Breda, North Brabant, Netherlands
- Catharina hospital — Eindhoven, North Brabant, Netherlands
- Amsterdam University Medical Center — Amsterdam, North Holland, Netherlands
- Leiden University Medical Center — Leiden, South Holland, Netherlands
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.